Johnson & Johnson stock slips despite fresh bullish calls — what investors watch before earnings
New York, Jan 5, 2026, 20:16 EST — Market closed Johnson & Johnson shares ended down 1.47% at $204.31 on Monday, giving back early gains even as Wall Street analysts reiterated bullish calls on the healthcare conglomerate. StreetInsider.com The move matters because investors are heading into a dense stretch of company updates, with management set to speak at the JPMorgan Healthcare Conference next week and to deliver fourth-quarter results later this month. In a market that has leaned into cyclical names, defensive stocks like J&J often need a clean guidance message to keep money flowing in. JNJ.com+2investor.jnj.com+2 Analysts are also